$750k Strides testosterone gel class action settlement
Who qualifies
The class action settlement benefits consumers who purchased Strides testosterone gel between June 1, 2022, and July 31, 2025.
Where: Nationwide / see notice
Proof needed
NDC number or other manufacturer identification
About this settlement
Strides Pharma has agreed to a $750,000 class action settlement to resolve claims that its testosterone gel products were contaminated with benzene, a known carcinogen. The Strides settlement benefits consumers who purchased Strides testosterone gel between June 1, 2022, and July 31, 2025. According to a class action lawsuit, Strides’ testosterone gel products were contaminated with benzene , a known human carcinogen, during the manufacturing process due to Strides’ alleged negligence. Plaintiffs in the case say they would not have purchased the contaminated testosterone gel products if they…
Details
- Case
- Painter v. Strides Pharma Inc. , Case No. 7:25-CV-4189, in the U.S. District Court for the Southern District of New York
- Administrator
- Painter v. Strides Pharma Inc. Settlement P.O. Box 301134
- Settlement fund
- $750k
- Seen on
- Discuss in
- Healthcare
Settlement Owl is a discovery tool, not a law firm or settlement administrator. Eligibility is decided solely by the official class definition — confirm every detail on the official settlement website before filing. Payout figures are estimates set by the settlement and may be reduced pro rata.